These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1644809

  • 1. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1.
    Kosfeld MD, Frazier WA.
    J Biol Chem; 1992 Aug 15; 267(23):16230-6. PubMed ID: 1644809
    [Abstract] [Full Text] [Related]

  • 2. Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli.
    Kosfeld MD, Pavlopoulos TV, Frazier WA.
    J Biol Chem; 1991 Dec 25; 266(36):24257-9. PubMed ID: 1761530
    [Abstract] [Full Text] [Related]

  • 3. The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
    Prater CA, Plotkin J, Jaye D, Frazier WA.
    J Cell Biol; 1991 Mar 25; 112(5):1031-40. PubMed ID: 1999454
    [Abstract] [Full Text] [Related]

  • 4. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin.
    Kosfeld MD, Frazier WA.
    J Biol Chem; 1993 Apr 25; 268(12):8808-14. PubMed ID: 8473325
    [Abstract] [Full Text] [Related]

  • 5. Platelet thrombospondin mediates attachment and spreading of human melanoma cells.
    Roberts DD, Sherwood JA, Ginsburg V.
    J Cell Biol; 1987 Jan 25; 104(1):131-9. PubMed ID: 3793757
    [Abstract] [Full Text] [Related]

  • 6. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion.
    Guo NH, Krutzsch HC, Nègre E, Vogel T, Blake DA, Roberts DD.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):3040-4. PubMed ID: 1557410
    [Abstract] [Full Text] [Related]

  • 7. Diverse mechanisms for cell attachment to platelet thrombospondin.
    Adams JC, Lawler J.
    J Cell Sci; 1993 Apr 01; 104 ( Pt 4)():1061-71. PubMed ID: 8314891
    [Abstract] [Full Text] [Related]

  • 8. Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis.
    Guo NH, Krutzsch HC, Nègre E, Zabrenetzky VS, Roberts DD.
    J Biol Chem; 1992 Sep 25; 267(27):19349-55. PubMed ID: 1527055
    [Abstract] [Full Text] [Related]

  • 9. Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.
    Clezardin P, Lawler J, Amiral J, Quentin G, Delmas P.
    Biochem J; 1997 Feb 01; 321 ( Pt 3)(Pt 3):819-27. PubMed ID: 9032471
    [Abstract] [Full Text] [Related]

  • 10. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC, Lawler J.
    Mol Biol Cell; 1994 Apr 01; 5(4):423-37. PubMed ID: 7519904
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin.
    Sipes JM, Guo N, Nègre E, Vogel T, Krutzsch HC, Roberts DD.
    J Cell Biol; 1993 Apr 01; 121(2):469-77. PubMed ID: 8468356
    [Abstract] [Full Text] [Related]

  • 12. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
    Merle B, Malaval L, Lawler J, Delmas P, Clezardin P.
    J Cell Biochem; 1997 Oct 01; 67(1):75-83. PubMed ID: 9328841
    [Abstract] [Full Text] [Related]

  • 13. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins.
    Tuszynski GP, Rothman VL, Deutch AH, Hamilton BK, Eyal J.
    J Cell Biol; 1992 Jan 01; 116(1):209-17. PubMed ID: 1730745
    [Abstract] [Full Text] [Related]

  • 14. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B, Leung L, el Ghissasi H, Mercier N, McGregor J.
    Biochem J; 1992 May 15; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain.
    Tuszynski GP, Rothman VL, Papale M, Hamilton BK, Eyal J.
    J Cell Biol; 1993 Jan 15; 120(2):513-21. PubMed ID: 8421063
    [Abstract] [Full Text] [Related]

  • 16. Interactions of a laminin-binding peptide from a 33-kDa protein related to the 67-kDa laminin receptor with laminin and melanoma cells are heparin-dependent.
    Guo NH, Krutzsch HC, Vogel T, Roberts DD.
    J Biol Chem; 1992 Sep 05; 267(25):17743-7. PubMed ID: 1387642
    [Abstract] [Full Text] [Related]

  • 17. Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide.
    Zabrenetzky VS, Kohn EC, Roberts DD.
    Cancer Res; 1990 Sep 15; 50(18):5937-42. PubMed ID: 2393863
    [Abstract] [Full Text] [Related]

  • 18. Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.
    Asch AS, Tepler J, Silbiger S, Nachman RL.
    J Biol Chem; 1991 Jan 25; 266(3):1740-5. PubMed ID: 1703153
    [Abstract] [Full Text] [Related]

  • 19. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins.
    Gao AG, Frazier WA.
    J Biol Chem; 1994 Nov 25; 269(47):29650-7. PubMed ID: 7525586
    [Abstract] [Full Text] [Related]

  • 20. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin.
    Vogel T, Guo NH, Krutzsch HC, Blake DA, Hartman J, Mendelovitz S, Panet A, Roberts DD.
    J Cell Biochem; 1993 Sep 25; 53(1):74-84. PubMed ID: 8227183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.